» Articles » PMID: 39594153

Comparative Safety Profiles and Usage Patterns of Iodinated Contrast Media in Medical Imaging

Overview
Specialty Radiology
Date 2024 Nov 27
PMID 39594153
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aimed to analyze the usage patterns and hypersensitivity reaction (HSR) profiles of six nonionic iodinated contrast media (ICMs) used in computed tomography (CT) to enhance patient safety and inform evidence-based contrast agent selection.

Methods: We retrospectively reviewed 248,209 CT scans obtained between January 2020 and December 2022. Six ICMs (iomeprol, iohexol, ioversol, iopromide, iodixanol, and iobitridol) were compared on the basis of their usage rates, HSR incidence, and severity. This study also evaluated the impact of premedication protocol reinforcement and assessed the quarterly HSR rates.

Results: Among the 248,209 CT scans, 1603 (0.65%) were associated with HSRs. Most HSRs were mild (86.2%), with moderate (10.9%) and severe (2.9%) reactions being less common. Four ICMs were used as first-line agents and two ICMs were used as second-line agents. The second-line agents, iobitridol and iodixanol, exhibited 7-8 times higher HSR rates compared to the first-line agents. A modified premedication protocol implemented in mid-2022 significantly reduced the incidence of moderate HSRs ( = 0.0075). The quarterly analysis indicated a trend in higher HSR rates in the first quarter and a statistically significant increase in severe HSRs in the third quarter ( = 0.033).

Conclusions: These findings highlight the importance of tailored premedication protocols and a 7-8 times higher rate of HSR with second-line agents in contrast-enhanced imaging. Future research should focus on elucidating the mechanisms underlying these variations to further refine contrast agent selection and management strategies.

References
1.
Park H, Son J, Kim T, Kang M, Han K, Kim E . Relationship between Lower Dose and Injection Speed of Iodinated Contrast Material for CT and Acute Hypersensitivity Reactions: An Observational Study. Radiology. 2019; 293(3):565-572. DOI: 10.1148/radiol.2019190829. View

2.
Kim S, Jeon K, Jung J, Park H, Lee W, Lee J . Substitution with Low-Osmolar Iodinated Contrast Agent to Minimize Recurrent Immediate Hypersensitivity Reaction. Radiology. 2023; 309(1):e222467. DOI: 10.1148/radiol.222467. View

3.
Wang C, Cohan R, Ellis J, Caoili E, Wang G, Francis I . Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008; 191(2):409-15. DOI: 10.2214/AJR.07.3421. View

4.
An J, Jung H, Kwon O, Kang Y, Lee J, Won H . Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database. J Allergy Clin Immunol Pract. 2019; 7(7):2205-2211. DOI: 10.1016/j.jaip.2019.02.035. View

5.
Sohn K, Seo J, Kang D, Lee S, Kang H . Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast. Invest Radiol. 2021; 56(8):480-485. DOI: 10.1097/RLI.0000000000000765. View